Dear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
See More
Dear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
See MoreDear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
This page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current location site or be switched to your location?
Western blot analysis of p130Cas (pY249) in human Burkitt’s lymphoma. Lysates from control (left panel) and hydrogen peroxide-activated (right panel) Ramos cells were probed with purified mouse anti-p130Cas (pY249) monoclonal antibody) at concentrations of 0.125 (lanes 1 and 4), 0.0625 (lanes 2 and 5), and 0.0312 µg/ml (lanes 3 and 6). p130Cas (pY249) is identified as a band of 130 kDa in the treated cells.
Western blot analysis of p130Cas (pY249) in human Burkitt’s lymphoma. Lysates from control (left panel) and hydrogen peroxide-activated (right panel) Ramos cells were probed with purified mouse anti-p130Cas (pY249) monoclonal antibody) at concentrations of 0.125 (lanes 1 and 4), 0.0625 (lanes 2 and 5), and 0.0312 µg/ml (lanes 3 and 6). p130Cas (pY249) is identified as a band of 130 kDa in the treated cells.
Western blot analysis of p130Cas (pY249) in human Burkitt’s lymphoma. Lysates from control (left panel) and hydrogen peroxide-activated (right panel) Ramos cells were probed with purified mouse anti-p130Cas (pY249) monoclonal antibody) at concentrations of 0.125 (lanes 1 and 4), 0.0625 (lanes 2 and 5), and 0.0312 µg/ml (lanes 3 and 6). p130Cas (pY249) is identified as a band of 130 kDa in the treated cells.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
p47v-crk (v-Crk) is the product of a transforming gene, v-crk, that was isolated from avian sarcoma viruses. The v-Crk protein is a fusion product of viral Gag protein and a part of cellular Crk that includes SH2 and SH3 domains. v-Crk-induced transformation increases tyrosine phosphorylation of several cellular proteins, including p130Cas (CRK-associated substrate). The p130Cas is tightly associated with v-Crk via the SH2 domain of v-Crk. Tyrosine phosphorylation of p130Cas occurs in conjunction with cellular transformation in cells that express v-Src or v-Crk. This phosphorylation leads to a change in p130Cas localization from the cytoplasm to the cell membrane and, possibly, to the nucleus. Since p130Cas also associates with v-Src, it may be a v-Src substrate. Several phosphorylation sites have been described in p130Cas upon Fibroblast Growth Factor stimulation, and phosphorylated tyrosine (Y249) might function as a binding site for the Crk-adaptor molecule.
The J169-757.12.2 monoclonal antibody recognizes the phosphorylated Y249 of human p130Cas. The orthologous phosphorylation sites in mouse and rat p130Cas are Y253 and Y347, respectively.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.